U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07360483) titled 'Treatment of Hypertrophic Scars Using Fractional CO2 Laser Alone in Comparison With Adding Botulinum Toxin Either Through Intralesional Injection or Assisted Drug Delivery' on Dec. 27, 2025.
Brief Summary: The current study aimed to evaluate the effectiveness of fractional laser treatment alone and fractional laser combined with botulinum toxin A, delivered either through injections or topical application fractional laser-assisted drug delivery (FLADD) in hypertrophic burn scar
Study Start Date: Jan. 01, 2025
Study Type: INTERVENTIONAL
Condition:
Hypertrophic Scars
Intervention:
DRUG: Botulinum toxin type A (Botox(R), Allergan...